Navigation Links
Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinson's symptoms
Date:8/13/2007

e neurons. The truth is, if you look at postmortem Parkinson's disease brains, you will see that both dopamine and norepinephrine neurons are gone," Dr. Weinshenker explains. "We know that norepinephrine is important for regulating the activity of dopamine neurons, so we suspected that the dopamine neurons and the norepinephrine neurons function in concert. As the dopamine neurons start dying, the norepinephrine neurons compensate by signaling the surviving dopamine cells to dramatically increase their activity and the output of dopamine. Eventually, the norepineprhine neurons die, the surviving dopamine neurons lose their ability to release extra dopamine, and symptoms start to appear."

To test their hypothesis, the researchers gave healthy, one-year-old mice the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine (MPTP) at a dose that kills about 80 percent of the dopamine cells, but observed no motor impairments in the mice. Surprisingly, when they tested mice unable to synthesize norepinephrine and that have trouble releasing dopamine properly, they observed symptoms of Parkinson's disease including resting tremor, hunched posture and deficits in coordinated movement. These results indicate that having a normal complement of dopamine neurons is not enough for normal motor function; norepinephrine also needs to be present to ensure proper dopamine release.

"Although there are no cures for Parkinson's disease, some moderately effective treatments are available, but most target the dopamine neurons only and are effective for only a limited amount of time. In light of this study, it's quite possible that simultaneously treating both the dopamine and norepinephrine loss could further ameliorate the symptoms of Parkinson's disease, says Dr. Weinshenker.


'/>"/>

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Gene study links endometriosis, infertility
2. Study reveals how stress can make you sick
3. Study points out that HIV vaccine may not be accepted easily
4. A new study surpasses Gene Therapy Hurdle
5. Tomato Sauce reduces Cancer Risk- Study
6. A question on study of Adult Stem Cell
7. Study on obesity and heart failure
8. National Lung Study in the process
9. Marijuana gateway theory strengthened by study of twins
10. Old theory of adaptation confirmed by new study
11. Study casts doubt on keyboard ills
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Average Annual Medical Premium Costs Increased 6%, Says 2008 Benefit Plan Report from C&B Consulting 2Health News:JUVA Skin & Laser Center Introduces Affirm CO2 to New York City Laser Resurfacing Clients 2Health News:Chiltern's Resourcing Solutions Division Appoints New Managers to Spain and the United Kingdom 2Health News:Stiefel Laboratories Completes Acquisition of Barrier Therapeutics 2Health News:Stiefel Laboratories Completes Acquisition of Barrier Therapeutics 3Health News:The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance 2Health News:The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance 3Health News:The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance 4Health News:The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance 5Health News:The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance 6Health News:The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance 7Health News:The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance 8Health News:The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance 9Health News:The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance 10Health News:The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance 11Health News:NHP Reports Second Quarter 2008 Earnings 2Health News:NHP Reports Second Quarter 2008 Earnings 3Health News:NHP Reports Second Quarter 2008 Earnings 4Health News:NHP Reports Second Quarter 2008 Earnings 5Health News:NHP Reports Second Quarter 2008 Earnings 6Health News:NHP Reports Second Quarter 2008 Earnings 7Health News:NHP Reports Second Quarter 2008 Earnings 8Health News:NHP Reports Second Quarter 2008 Earnings 9Health News:NHP Reports Second Quarter 2008 Earnings 10Health News:NHP Reports Second Quarter 2008 Earnings 11Health News:NHP Reports Second Quarter 2008 Earnings 12Health News:NHP Reports Second Quarter 2008 Earnings 13Health News:NHP Reports Second Quarter 2008 Earnings 14
Breaking Medicine Technology:AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 3China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 2China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 3New National Pharmaceutical Council Report Provides Guidance on Evaluating Comparative Effectiveness Studies 2Half of the fish consumed globally is now raised on farms study finds 9813 1Half of the fish consumed globally is now raised on farms study finds 9813 2Half of the fish consumed globally is now raised on farms study finds 9813 3Let Orthopedic Surgery Wait Until Morning When Possible 56337 1REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 1REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 2REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 3REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 4REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 5